Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2017 Annual Report on Form 10-K - PDF 2017 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$12.61
Change (%) Stock is Down 0.49 (3.74%)
Volume1,094,752
Data as of 11/16/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
11/08/18OraSure Technologies to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum
BETHLEHEM, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the Canaccord Genuity Medical Technologies & Diagnostics Forum.  The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on November 15, 2018, at approximately 1:00 PM Eastern Ti... 
Printer Friendly Version
11/07/18OraSure Announces 2018 Third Quarter Financial Results
BETHLEHEM, PA., Nov. 07, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the three and nine months ended September 30, 2018. Financial Highlights Net revenues for the third quarter of 2018 were $45.9 million, an 8% increase from the third quarter of 2017. Net product revenues were $43.5 million, representing a 6% increase from the third quarter of 20... 
Printer Friendly Version
10/08/18OraSure Technologies Earnings Conference Call Invitation
2018 Third Quarter Earnings Conference Call Wednesday, November 7, 2018, 5:00 p.m. ET BETHLEHEM, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2018 third quarter financial results, 2018 fourth quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 7, 2018.  November 7, 2018 Schedule 4:00 p.m. ET 2018 third quarter financial ... 
Printer Friendly Version
09/26/18OraSure Technologies to Present at the Cantor Global Healthcare Conference
BETHLEHEM, Pa., Sept. 26, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the Cantor Global Healthcare Conference. The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on October 3, 2018, at approximately 9:45 AM Eastern Time (6:45 AM Pacific Time). ... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet